APA (7th ed.) Citation

Iida, Y., & Harada, M. Local cell therapy using CCL19-expressing allogeneic mesenchymal stem cells exerts robust antitumor effects by accumulating CD103+ IL-12-producing dendritic cells and priming CD8+ T cells without involving draining lymph nodes. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Iida, Yuichi, and Mamoru Harada. Local Cell Therapy Using CCL19-expressing Allogeneic Mesenchymal Stem Cells Exerts Robust Antitumor Effects by Accumulating CD103+ IL-12-producing Dendritic Cells and Priming CD8+ T Cells Without Involving Draining Lymph Nodes. BMJ Publishing Group.

MLA (9th ed.) Citation

Iida, Yuichi, and Mamoru Harada. Local Cell Therapy Using CCL19-expressing Allogeneic Mesenchymal Stem Cells Exerts Robust Antitumor Effects by Accumulating CD103+ IL-12-producing Dendritic Cells and Priming CD8+ T Cells Without Involving Draining Lymph Nodes. BMJ Publishing Group.